Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Senti Biosciences Holdings, Inc. - Common Stock (NQ:SNTI)

0.8619 -0.0782 (-8.32%)
Streaming Delayed Price Updated: 3:48 PM EDT, May 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Senti Biosciences Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Senti Biosciences? ↗
 
Via Benzinga
News headline image
SNTI Stock Earnings: Senti Biosciences Reported Results for Q2 2024 ↗
Senti Biosciences just reported results for the second quarter of 2024. 
Via InvestorPlace
News headline image
SNTI Stock Earnings: Senti Biosciences Reported Results for Q1 2024 ↗
Senti Biosciences just reported results for the first quarter of 2024. 
Via InvestorPlace
News headline image
AT&T To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
 
Via Benzinga
News headline image
US Stock Futures Dip As Dollar Slides And Treasuries Rise After S&P Hits 54th All-Time High This Year: Analyst Sees 'Further Upside' Of Around 10% In 2025 From Current Levels ↗
U.S. stock futures were in negative territory during Tuesday’s premarket hours as the dollar slipped to 106.3 level. 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Dow Dips 150 Points; ISM Manufacturing PMI Tops Estimates ↗
 
Via Benzinga
Topics Stocks
News headline image
Why Is Senti Biosciences Stock Surging Over 400% On Monday? ↗
Senti Biosciences shares surge as SENTI-202 trial shows promise in AML patients; company secures $37.6M in private equity funding. 
Via Benzinga
News headline image
Nasdaq Gains Over 100 Points; Li Auto Delivers 48,740 Vehicles In November ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Senti Bio Announces Reverse Stock Split
Shares expected to begin trading on split-adjusted basis on July 18, 2024 
From Senti Biosciences, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
Pre-market stock movers are worth diving into this morning as we break down all of the biggest news moving shares on Tuesday! 
Via InvestorPlace
News headline image
Complete Solaria, Senti, and POET: 3 High Volume Penny Stocks
Penny stocks are risky, but follow the money to find winners. Stocks with significant volume spikes may have what it takes for higher share prices. 
Via MarketBeat
News headline image
Senti Biosciences (SNTI) Stock Is Up Over 100%: What's Happening? ↗
Senti Biosciences shares are trading higher by 102.6% during Monday's session. The company was awarded $8 million from the California Institute for Regenerative Medicines. 
Via Benzinga
News headline image
Senti Bio Awarded California Institute for Regenerative Medicines (CIRM) Grant for Clinical Development of Logic Gated CAR-NK Cell Therapy
$8M grant supports ongoing Phase 1 clinical trial of SENTI-202 for the treatment of relapsed/refractory hematologic malignancies including acute myeloid leukemia 
From Senti Biosciences, Inc.
Via GlobeNewswire
News headline image
Why Is Beyond Air (XAIR) Stock Down 22% Today? ↗
Beyond Air stock is down on Tuesday as investors in XAIR react to the company mixed earnings report for the first quarter of the year. 
Via InvestorPlace
News headline image
Why Is Faraday Future (FFIE) Stock Down 27% Today? ↗
Faraday Future stock is down on Tuesday after the troubled EV company announced plans for a reverse split of FFIE shares. 
Via InvestorPlace
News headline image
Why Is Senti Biosciences (SNTI) Stock Up 32% Today? ↗
Senti Biosciences stock is up on Tuesday with heavy pre-market trading of SNTI shares despite a lack of news from the company. 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
Pre-market stock movers are worth checking out on Tuesday as we get into all of the hottest news worth reading about this morning! 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
From Senti Biosciences, Inc.
Via GlobeNewswire
News headline image
Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate Highlights
From Senti Biosciences, Inc.
Via GlobeNewswire
News headline image
Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML)
From Senti Biosciences, Inc.
Via GlobeNewswire
News headline image
SNTI Stock Earnings: Senti Biosciences Misses EPS for Q4 2023 ↗
SNTI stock results show that Senti Biosciences missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights
From Senti Biosciences, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.